Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1994-04-19
1996-01-30
Warden, Jill
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530306, 530324, A61K 3835
Patent
active
054880335
ABSTRACT:
Administration of a corticotropin-releasing factor (or a salt or analog thereof) decreases the leakage of blood components into tissues produced by various adverse medical conditions. Thus, treatments with corticotropin-releasing factor are useful in systemic inflammatory conditions.
REFERENCES:
patent: 3980778 (1976-09-01), Ayer et al.
patent: 4404198 (1983-09-01), Kelley
patent: 4415558 (1983-11-01), Vale, Jr. et al.
patent: 4489163 (1984-12-01), Rivier et al.
patent: 4517181 (1985-05-01), Ling et al.
patent: 4528189 (1985-07-01), Lederis et al.
patent: 4533654 (1985-08-01), Lederis et al.
patent: 4579844 (1986-04-01), Rovee et al.
patent: 4594329 (1986-06-01), Vale, Jr. et al.
patent: 4605642 (1986-08-01), Rivier et al.
patent: 4801612 (1989-01-01), Wei
patent: 5137871 (1992-08-01), Wei
patent: 5306710 (1994-04-01), Wei
Bernhagen et al., "MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia" Nature, vol. 365, 21 Oct. pp. 756-759 (1993).
Wei et al., "Peptides of the . . . Rat Pawskin," European Journal of Pharmacology, 168, pp. 81-86 (1989).
Chan et al., "Phospholipid Degradation and Edema Development in Cold-Injured Rat Brain", Brain Research, vol. 277, No. 2 (1983), pp. 329-337.
Esch et al., "Isolation and Characterization of the Bovine Hypothalamic Corticotropin-Releasing Factor", Biochem. & Biophy. Res. Comm., vol. 122, No. 3 (1984), pp. 899-905.
Ling et al., "Isolation and Characterization of Caprine Corticotropin-Releasing Factor", Biochem. & Biophy. Res. Comm., vol. 122, No. 3 (1984), pp. 1218-1224.
Melchiorri et al., "Action of Sauvagine on the Mesenteric Vascular Bed of the Dog", Regulatory Peptides, vol. 2, (1981), pp. 1-13.
Patthy et al., "Isolation and Amino Acid Sequence of Corticotropin-Releasing Factor from Pig Hypothalami", Proc. Natl. Acad. Sci. USA, vol. 82, No. 24, (1985), pp. 8762-8766.
Pinckard et al., "Platelet-Activating Factors", Inflammation: Basic Principles and Clinical Correlates, Gallin et al., eds., New York: Raven Press (1988), pp. 139-167.
Stern et al., "Ibuprofen in the Treatment of UV-B-Induced Inflammation," Arch. Dermatol., vol. 121, No. 4 (1985), pp. 508-512.
The Regents of the University of California
Touzeau P. Lynn
Warden Jill
LandOfFree
Treatment to reduce edema does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment to reduce edema, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment to reduce edema will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-156620